Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Current Assets (2016 - 2026)

Bioceres Crop Solutions' Current Assets history spans 11 years, with the latest figure at $260.7 million for Q1 2026.

  • On a quarterly basis, Current Assets changed N/A to $260.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $260.7 million, a N/A change, with the full-year FY2025 number at $308.3 million, down 24.56% from a year prior.
  • Current Assets hit $260.7 million in Q1 2026 for Bioceres Crop Solutions, down from $308.3 million in the prior quarter.
  • Over the last five years, Current Assets for BIOX hit a ceiling of $408.7 million in Q2 2024 and a floor of $260.7 million in Q1 2026.
  • Historically, Current Assets has averaged $334.5 million across 5 years, with a median of $308.3 million in 2025.
  • Biggest five-year swings in Current Assets: skyrocketed 40.77% in 2022 and later dropped 24.56% in 2025.
  • Tracing BIOX's Current Assets over 5 years: stood at $297.7 million in 2022, then surged by 33.39% to $397.1 million in 2023, then grew by 2.91% to $408.7 million in 2024, then decreased by 24.56% to $308.3 million in 2025, then dropped by 15.44% to $260.7 million in 2026.
  • Business Quant data shows Current Assets for BIOX at $260.7 million in Q1 2026, $308.3 million in Q2 2025, and $408.7 million in Q2 2024.